These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18313982)

  • 21. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.
    León AR; Abraham WT; Brozena S; Daubert JP; Fisher WG; Gurley JC; Liang CS; Wong G;
    J Am Coll Cardiol; 2005 Dec; 46(12):2298-304. PubMed ID: 16360062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.
    Shimano M; Tsuji Y; Yoshida Y; Inden Y; Tsuboi N; Itoh T; Suzuki H; Muramatsu T; Okada T; Harata S; Yamada T; Hirayama H; Nattel S; Murohara T
    Europace; 2007 Oct; 9(10):869-74. PubMed ID: 17557768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.
    Valzania C; Gadler F; Eriksson MJ; Olsson A; Boriani G; Braunschweig F
    Eur J Heart Fail; 2007; 9(6-7):644-50. PubMed ID: 17347041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronisation therapy versus dual site right ventricular pacing in a patient with permanent pacemaker and congestive heart failure.
    Satish OS; Yeh KH; Wen MS; Wang CC
    Europace; 2005 Jul; 7(4):380-4. PubMed ID: 15944097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay.
    Yeim S; Bordachar P; Reuter S; Laborderie J; O'Neill MD; Lafitte S; Deplagne A; Garrigue S; Roudaut R; Jais P; Haissaguerre M; Dossantos P; Clementy J
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):970-5. PubMed ID: 17669079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study.
    Gold MR; Feliciano Z; Gottlieb SS; Fisher ML
    J Am Coll Cardiol; 1995 Oct; 26(4):967-73. PubMed ID: 7560625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy.
    Yoshida K; Seo Y; Yamasaki H; Tanoue K; Murakoshi N; Ishizu T; Sekiguchi Y; Kawano S; Otsuka S; Watanabe S; Yamaguchi I; Aonuma K
    Eur Heart J; 2007 Nov; 28(21):2610-9. PubMed ID: 17947217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.
    Murphy NF; O'Loughlin C; Ledwidge M; McCaffrey D; McDonald K
    Eur J Heart Fail; 2007 Dec; 9(12):1196-204. PubMed ID: 18039520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy.
    Brandt RR; Reiner C; Arnold R; Sperzel J; Pitschner HF; Hamm CW
    Eur Heart J; 2006 Jan; 27(2):187-92. PubMed ID: 16223745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.